R

X

REBILLARD , Xavier

Last name: REBILLARD

First name: Xavier

December 2015 (v1)

Journal article

Metadata-only

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France

Houédé, Nadine Beuzeboc, Philippe Gourgou, Sophie

AbstractBackgroundCOU-AA-301 trial has proved that abiraterone acetate (AA), a selective inhibitor of androgen biosynthesis, improved overall survival (OS) of patients with metastatic castration resistant prostate cancer (mCRPC) after a first line of docetaxel. Based on this result, a Temporary Authorization for Use (TAU) was performed between...

Uploaded on: February 28, 2023
March 1, 2015 (v1)

Journal article

Metadata-only

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use program in France.

Houede, Nadine Beuzeboc, Philippe Gourgou, Sophie

264 Background: COU-AA-301 trial has proved that abiraterone acetate (AA), a selective inhibitor of androgen biosynthesis, improved overall survival (OS) of patients with metastatic castration resistant prostate cancer (mCRPC) after a first line of docetaxel. Based on this result, a temporary use authorisation (TUA) was performed between...

Uploaded on: December 3, 2022